| 摘要 |
he present invention relates to new pharmaceutical forms of the fluoxetine-based therapeutic substance and, more precisely, to the composition and production process of effervescent fluoxetine tablets which are a pharmaceutical form conveying to the patient's organism the drastic substance in its liquid phase, for efficient bio-availability resulted from the increased absorption degree of the liquid phase medicine. |
